Matthew Shaun Bowden

age:

46 years

appointments:

23 active

1 prior

primary industry:

Other professional, scientific and technical activities

about Matthew

Since 2019, Mr Bowden has been a director of 24 companies, the current directorship have a combined turnover of approximately £3b.

Combined Valuation

£39.9b

Combined Turnover

£3b

active directorships over time

company
turnover
valuation
start
end
status
role
kudos pharmaceuticals limited£670m£11.6bFeb 2019-OpenDirector
medimmune limited£2.2b£11.5bFeb 2019-OpenDirector
cambridge antibody technology group limited-£7.1bFeb 2019-OpenDirector
azenco4 limited-£2.6bFeb 2019-OpenDirector
astra pharmaceuticals limited-£2.5bFeb 2019-OpenDirector
zenco (no. 8) limited-£2.4bFeb 2019-OpenDirector
astrazeneca us investments limited-£1.3bFeb 2019-OpenDirector
astrazeneca investments limited-£596.6mFeb 2019-OpenDirector
medimmune u.k. limited£78.5m£130.4mFeb 2019-OpenDirector
astrazeneca japan limited-£120.7mFeb 2019-OpenDirector
astrapharm-£28.5mFeb 2019-OpenDirector
zeneca finance (netherlands) company-£2.3mFeb 2019-OpenDirector
kudos horsham limited-£2mFeb 2019-OpenDirector
astrazeneca finance limited-£236kFeb 2019-OpenDirector
azenco2 limited-£257.4Feb 2019-OpenDirector
astrazeneca quest limited-£257.4Feb 2019-OpenDirector
astrazeneca share trust limited-£257.4Feb 2019-OpenDirector
astrazeneca employee share trust limited-£257.4Feb 2019-OpenDirector
astrazeneca china uk limited-£227.7Feb 2019-OpenDirector
arrow therapeutics limited-£97.8Feb 2019-OpenDirector
astrazeneca nominees limited-£4.6Feb 2019-OpenDirector
astrazeneca death in service trustee limited-£2.3Jan 2021-OpenDirector
ardea biosciences limited-£2Feb 2019-OpenDirector